Lantern Pharma Revenue and Competitors
Estimated Revenue & Valuation
- Lantern Pharma's estimated annual revenue is currently $1.5M per year.
- Lantern Pharma's estimated revenue per employee is $48,774
Employee Data
- Lantern Pharma has 31 Employees.
- Lantern Pharma grew their employee count by 7% last year.
Lantern Pharma's People
Name | Title | Email/Phone |
---|---|---|
1 | Co-Founder | Reveal Email/Phone |
2 | VP Clinical Development | Reveal Email/Phone |
3 | Chief Scientific Officer | Reveal Email/Phone |
4 | Chief Financial Officer and Secretary | Reveal Email/Phone |
5 | Chief Medical Officer | Reveal Email/Phone |
6 | CEO, President and Director | Reveal Email/Phone |
7 | Chief Scientific Officer | Reveal Email/Phone |
8 | Senior Finance Manager | Reveal Email/Phone |
9 | Senior Research Scientist & Program Manager | Reveal Email/Phone |
10 | Bioinformatics & Platform Development Manager | Reveal Email/Phone |
Lantern Pharma Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $7.9M | 65 | -44% | $33.2M | N/A |
#2 | $1.3M | 16 | 7% | N/A | N/A |
#3 | $11.9M | 85 | -11% | $18.3M | N/A |
#4 | $2.8M | 29 | -87% | N/A | N/A |
#5 | $1.3M | 15 | N/A | N/A | N/A |
#6 | $0.8M | 10 | -60% | N/A | N/A |
#7 | $1.5M | 18 | 6% | N/A | N/A |
#8 | $60.1M | 338 | -14% | $286.6M | N/A |
#9 | $2.1M | 21 | N/A | N/A | N/A |
#10 | $17.2M | 123 | 1% | $56.8M | N/A |
What Is Lantern Pharma?
Lantern Pharma, Inc. is a clinical stage pharmaceutical company developing new classes of precision cancer drugs with novel mechanisms of action, and also rescuing or revitalizing abandoned or failed cancer drugs using machine learning techniques, genomic data and precision oncology trials. Lantern Pharma recognizes that the high cost and low success rates in oncology drug development largely stem from the inability to appropriately stratify patient populations prior to enrollment, and also from the inability to fully elucidate mechanisms of action that can suggest potent combinations. Our approach which leverages our RADR platform helps to provide rapid, meaningful insight to both of these central problems in oncology. Lantern is focused on accelerating personalized cancer therapy development through the use of AI and genomic-based patient stratification.
keywords:N/AN/A
Total Funding
31
Number of Employees
$1.5M
Revenue (est)
7%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $8.1M | 31 | -9% | N/A |
#2 | $3.6M | 31 | N/A | N/A |
#3 | $7.2M | 31 | 0% | N/A |
#4 | $3.6M | 31 | -6% | N/A |
#5 | $6.1M | 31 | 0% | N/A |